Full text is available at the source.
Abstract
The platform achieved 29.2% single-cell droplets with a mitochondrial transfer efficiency of up to 56%.
- Mitochondrial transfer may enhance the functioning of senescent mesenchymal stem cells (MSCs).
- The inertial-focusing-assisted droplet microfluidic platform allows for high-throughput and precise control of mitochondrial transfer.
- Transferring 19 mitochondria from young adipose-derived MSCs to senescent ADSCs improved their proliferation and metabolic activities.
- The method reduced markers associated with cellular aging and reverted the senescent cells to a younger, MSC-like state.
- This technique could provide a novel approach for addressing mitochondrial-related diseases.
Simplified